Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Everolimus
- Therapeutic area
- Oncology & immunology
- Drug class
- Immunosuppressants / immunomodulators
- ATC
- L04
- Strength
- 0.25 mg
- Dosage form
- Tablet
- Pack
- 60's
- Registration no.
- 044829
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-12 02:58
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Certican (Everolimus) is used for
Everolimus is a targeted medicine that slows the growth of some cancers. It is a tablet that belongs to a group called mTOR blockers (kinase inhibitors). It is also used, under specialist care, to stop the body rejecting a transplanted kidney and for conditions linked to tuberous sclerosis. It is started and watched by specialist doctors, such as a cancer team or a transplant team, who arrange regular blood tests.
- Some advanced kidney cancers
- Some advanced neuroendocrine tumours (tumours of the stomach, bowel, lung or pancreas)
- Advanced breast cancer in women after the change of life, used with a hormone medicine
- Tumours and some seizures in people with tuberous sclerosis complex (specialist care)
- Helping to prevent rejection in some adults with a transplanted kidney (a different product, started by a transplant team)
Get medical help straight away if
- Call an ambulance or go to the emergency department for chest pain, severe trouble breathing, or swelling of the face, lips, tongue or throat with trouble breathing or swallowing. These can be signs of a serious allergic reaction, a blood clot or a heart problem.
- Contact your cancer or transplant team straight away for fever, chills, sore throat or other signs of infection. This medicine can weaken the body's defence against infection.
- Contact your team for a new or worsening cough, wheezing, breathlessness or fever. These can be signs of lung inflammation (pneumonitis).
- Contact your team for yellow skin or eyes, dark urine or pale stools. Hepatitis B can flare up again in people who have had it.
Side effects, warnings and interactions for Everolimus
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Certican 0.25 mg tablet
Certican 0.25 mg tablet contains Everolimus 0.25 mg. It is registered with DRAP by Nouveaux Pharma Limited (registration no. 044829). Its official price is PKR 19,385.90 for a pack of 60's, about PKR 323.10 per tablet. This price has applied since 23 July 2026. Certican is also available as 0.75 mg tablet. 3 other brands of Everolimus 0.25 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Certican
All 3 other brands of Everolimus 0.25 mg tablet in Pakistan
These 3 brands are alternatives (substitutes) to Certican: each contains Everolimus 0.25 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is EVERGRAF (Kaizen Pharmaceuticals (Pvt) Ltd) at PKR 208 per tablet; the highest is Evercan at PKR 264. All prices are official DRAP prices.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Certican, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Nouveaux Pharma Limited, Karachi
- DRAP registration
- 044829
- Phone
- +92 21 32313386
- Website
- https://www.nplpk.com/
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (60's). Current price PKR 19,385.90, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Certican 0.25 mg, 60's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/certican-0-25-mg-044829-60s-nouveaux-pharma-limited/ (accessed 12 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 19,385.90 | 2026-07-23 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 044829Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.